A detailed summary of the findings and conclusions of two extensive reports on research public-private partnerships in the EU: the Innovative Medicines Initiative (IMI) and the Bio-Based Industries (BBI) Joint Undertakings.

Despite strong calls from MEPs and the public, ExxonMobil and its lobby groups mobilise enough behind-the-scenes pressure to stop the European Parliament taking away its lobby badges

Given the upcoming revision of the Tobacco Products Directive, it is high time that the EU meets its obligations to ensure that lobbying by the tobacco industry to influence public officials faces tighter scrutiny and pro-active transparency.

In this seventh episode Vicky Cann from Corporate Europe Observatory and Nina Katzemich from LobbyControl dig into the so-called green credentials of the German Government. They explain how the Government’s ‘love affair’ with gas and its unconditional support for the automobile sector are two clear cut examples of how its EU Presidency, starting today, risks preventing effective climate action by the EU.

As the German Government gets ready to take over the EU Presidency, a new report by Corporate Europe Observatory and LobbyControl exposes how its for domestic industry could undermine effective climate action.

Germany will shortly take over the EU Council Presidency at a critical time. A new report looks at the German Government’s record in its own EU decision-making and exposes how time and again it is too close to corporate interests.

Journalist and Corporate Europe Observatory board member Jakub Patočka comments on the conflicts of interest scandals of the oligarch-turned-Czech Prime Minister – and explains how an injection of democracy is also needed at the EU level.

92 MEPs have urged Chancellor Angela Merkel to put transparency of decision-making in the Council, lobby transparency, and tackling privileged access to decision-makers at the heart of the upcoming German EU Presidency.

EU Watchdog Radio is a new podcast hosted jointly by Corporate Europe Observatory (CEO) and Counter Balance. In the sixth episode Martin Pigeon, researcher and campaigner at CEO and Marine Ejuryan, EU Advocacy manager at ‘Global Health Advocates’ (GHA) explain the content of two in-depth and damning reports they just published; These reports are about how, in the name of innovation, industrial lobbies have managed to control the use of at least 3.6 billion of euro in European public research funds.

EU research funds for helping people living with HIV in Africa so far appear to have only helped Sanofi’s profits.